VIRAGEN, INC.
865 S.W. 78th Avenue, Suite 100
Plantation, Florida 33324
October 22, 2003
VIA EDGAR
United States Securities and
Exchange
Commission
450 Fifth Street NW
Washington, DC 20549
Attn: Jeffrey P. Riedler
Assistant Director
| Re: |
Viragen, Inc. (the “Company”) Form S-3 Registration Statement Commission File No. 333-108073 |
Ladies and Gentlemen:
Viragen, Inc. hereby withdraws its pre-effective Registration Statement on Form S-3, filed on August 19, 2003 and assigned Commission File No. 333-108073 (the “Registration Statement”).
As described in the Company’s Current Report on Form 8-K filed October 2, 2003:
| • | On September 29, 2003, the Company consummated the sale of approximately $4.775 million of common stock and warrants; and | ||
| • | In connection therewith, the Common Stock Purchase Agreement dated March 31, 2003, which was the subject of the Registration Statement, was terminated. |
Accordingly, the Company is filing this RW to withdraw the Registration Statement.
| Very truly yours, | ||
| VIRAGEN, INC. | ||
| By: /s/ Dennis W. Healey | ||
|
|
||
|
Dennis W. Healey Executive Vice President |